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Abstract
Background/Aims: Utilization of a psychosocial screener to identify families affected by a 
disorder/difference of sex development (DSD) and at risk for adjustment challenges may facilitate 
efficient use of team resources to optimize care. The Psychosocial Assessment Tool (PAT) has 
been used in other pediatric conditions. The current study explored the reliability and validity of 
the PAT (modified for use within the DSD population; PAT-DSD).
Methods: Participants were197 families enrolled in the DSD-Translational Research Network 
(DSD-TRN) who completed a PAT-DSD during a DSD clinic visit. Psychosocial data were 
extracted from the DSD-TRN clinical registry. Internal reliability of the PAT-DSD was tested using 
the Kuder-Richardson-20 coefficient. Validity was examined by exploring the correlation of the 
PAT-DSD with other measures of caregiver distress and child emotional-behavioral functioning.
Results: One-third of families demonstrated psychosocial risk (27.9% “Targeted” and 6.1% 
“Clinical” level of risk). Internal reliability of the PAT-DSD Total score was high (α = 0.86); 4 of 8 
subscales met acceptable internal reliability. A priori predicted relationships between the PAT-
DSD and other psychosocial measures were supported. The PAT-DSD Total score related to 
measures of caregiver distress (r = 0.40, P < 0.001) and to both caregiver-reported and patient self-
reported behavioral problems (r = 0.61, P < 0.00; r = 0.37, P < 0.05).
Conclusions: This study provides evidence for the reliability and validity of the PAT-DSD. 
Given variability in the internal reliability across subscales, this measure is best used to screen for 
overall family risk, rather than to assess specific psychosocial concerns.
Keywords
Disorders of Sex Development; DSD; Interdisciplinary Care; Intersex; Screening; Psychometric 
evaluation
Introduction
Disorders/differences of sex development (DSD)1 are a heterogeneous group of congenital 
conditions in which a person’s sex chromosomes, gonads or anatomy develop atypically or 
are discordant [1]. DSD are classified into 3 categories: sex chromosome DSD, 46, XY DSD 
1There is a lack of agreement on the terminology used to describe these conditions; while “disorders of sex development” was 
proposed in the 2006 International DSD Consensus Statement (with the input of affected individuals and advocates) as a means of 
decreasing stigmatizing language and standardizing terminology to promote clinical and research rigor, many affected individuals 
prefer other terms such as “intersex” or diagnosis-specific terms.
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and 46,XX DSD, with wide variability in the acuity of medical issues. Some DSD require 
little-to-no immediate medical or surgical management (e.g., proximal hypospadias, a 
urogenital sinus with clitoromegaly), whereas features of some DSD can be life-threatening 
without swift medical care (e.g., salt-wasting in congenital adrenal hyperplasia) [2]. DSD 
may present with internal or external reproductive anatomical differences, gonadal tumor 
risk requiring surveillance or gonadectomy, and reduced prospects for fertility. In addition, 
affected individuals frequently need lifelong hormone replacement. In the face of these 
challenges, the majority of families navigating DSD demonstrate improved coping after 
initial post-diagnosis distress [3], characteristic of resilience [4]. However, some affected 
individuals and their parents report significant distress related to aspects of the DSD 
experiences, such as coping with health care experiences, stigma concerns, and confusion 
related to diagnosis and decision-making [3, 5–10].
Families managing these DSD experiences are not doing so in a vacuum – there are a host of 
psychosocial (e.g., psychological, socioeconomic) contextual factors that may impact family 
resilience in the face of medical challenges (for review [11]). Family resources, social 
support networks, parent and child emotional-behavioral functioning, and previous 
interactions with health care providers have been implicated in adjustment to chronic 
conditions and may be more influential in shaping health and well-being outcomes than 
disease or biomedical variables [12]. Assessing and intervening along these factors may be 
critical for enhancing the overall outcomes for patients and families managing chronic 
conditions, including DSD.
Comprehensive services addressing psychological and social factors for optimizing 
outcomes in families with a DSD have been recommended in multiple consensus statements 
and care guidelines [1, 13–15]. For example, most recently, the 2018 European DSD 
Consensus Statement recommends “Holistic health care”, defined as “a system of 
comprehensive patient care that considers the physical, emotional, social, economic, and 
spiritual needs of the patient” and “the needs of family members of patients” [16]. To 
accomplish this care, DSD guidelines consistently endorse a multidisciplinary team that 
includes subspecialties with expertise in behavioral health, defined as the interdisciplinary 
field focused on “the application of behavioral and biomedical science knowledge and 
techniques to the maintenance of health and prevention of illness and dysfunction” [17]. 
Behavioral health providers typically include team members from psychology, psychiatry, 
and/or social work, each with their own areas of expertise.
Unfortunately, more than a decade after the 2006 Consensus statement which highlighted the 
importance of multidisciplinary care [1], many DSD teams still do not offer universal 
comprehensive services, and often lack, in particular, behavioral health providers [18, 19]. 
Barriers to inclusion of behavioral health in DSD comprehensive care have not been 
delineated but likely include lack of access to behavioral health providers (with DSD 
expertise, especially), inadequate funding models for multidisciplinary care [20], and/or the 
financial and stigma-related barriers found in rural or remote resource-poor communities 
[21, 22]. Even when DSD teams do adhere to a multidisciplinary model including behavioral 
health, busy clinic schedules involving multiple providers may preclude behavioral health 
providers from spending sufficient time with any individual family to review all 
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psychosocial factors. For health care providers managing DSD care outside the context of a 
multidisciplinary team, involvement of behavioral health expertise may be even more 
challenging: for example, endocrinologists treating patients with DSD without a 
comprehensive team may be faced with recognizing psychosocial concerns, identifying 
community psychologists and helping families navigate barriers to access. Thus, families 
may not be receiving the behavioral health care that is needed. Indeed, in one study, 40% of 
the 317 parents of children with DSD noted that they had needed psychological support; of 
these parents identifying this need, 52% had not received any counseling [23].
Within the context of limited time or an incomplete multidisciplinary team, knowing which 
families are experiencing any of a range of psychosocial contextual challenges may be 
difficult for DSD care teams; while accurate identification of psychosocial challenges in 
DSD has not been investigated, research from general pediatric samples suggests that 
providers miss many patients/families experiencing difficulties and many patients/families 
do not readily discuss their psychosocial concerns [24, 25]. One strategy to better identify 
families experiencing challenges is to use some of the many validated measures available to 
assess numerous psychosocial factors that may impact family adjustment to a chronic 
condition. However, the use of multiple measures to assess the variety of potential risk 
factors poses an administrative burden within the health care system and can be limited by 1) 
the resources required to administer and score measures, 2) the behavioral health expertise 
required to interpret and communicate results, 3) financial costs to purchasing numerous 
measures, and 4) families’ willingness/ability to complete multiple measures. Preventive 
health models offer the framework to circumvent these barriers, particularly in terms of the 
screening approach, which involves the use of a brief validated measure to identify people 
currently or at risk of experiencing problems known to occur in a population [11]. Kazak 
and colleagues describe the Pediatric Psychosocial Preventative Health Model (PPPHM), 
which highlights 1) screening of all members of the population, 2) importance of universally 
delivering interventions that promote resiliency and prevent deterioration in family 
adaptation, and 3) providing specific interventions that match the level of need of families 
for whom risk factors are identified [11].
In line with this model [11], Kazak and colleagues developed the Psychosocial Assessment 
Tool (PAT) as a means of assessing risk and resiliency factors in families managing pediatric 
chronic conditions [26]. The PAT is a brief, broad screener of multiple psychosocial 
contextual factors that is used to triage families into 1 of 3 risk categories so that resources 
can be effectively and efficiently managed: Universal reflects transient distress but generally 
good adjustment; Targeted reflects families experiencing some acute distress and some 
psychosocial risk; and Clinical reflects on-going, escalating or high-intensity distress with 
multiple risk factors present. With few exceptions, studies employing the PAT find that the 
majority of families are coping well and fall into the Universal risk category (50%−76%), 
with fewer in the Targeted (19%−36%) and Clinical risk (3%−18%) levels [11]. The PAT 
was developed initially within the pediatric oncology population [26], and, with modest 
amendments in wording, has been used in multiple pediatric chronic illness populations such 
as kidney transplant [27], inflammatory bowel disease (IBD) [28] and headache [29]. In 
health care settings providing DSD care, utilization of a validated single screening measure 
to detect families at elevated psychosocial risk across multiple factors has the potential to 
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facilitate the triaging and optimizing of resources and may overcome some of the barriers 
associated with providing integrated behavioral health care. However, the psychometric 
characteristics of the PAT when used within the context of DSD must first be determined.
Thus, the current study explored the reliability and construct validity of the PAT in the 
context of DSD care, utilizing clinical registry data from the DSD-Translational Research 
Network (DSD-TRN). The DSD-TRN is a clinical research network created in 2011, with 
funding from the National Institutes of Health, to advance discovery of genetic causes of 
DSD, standardize the diagnostic process, and systematically evaluate relationships between 
treatment strategies and health and quality of life outcomes of patients and families. 
Inclusion criteria for the DSD-TRN registry specifies that patients meet the DSD definition 
provided by the International Consensus Conference on Intersex in that they have “any 
congenital condition in which development of chromosomal, gonadal or anatomical sex is 
atypical” [1] and that they (or their caregivers) have provided consent for data to be entered 
into the registry. The governance structure of the NIH-supported DSD-TRN entails a 
Network Leadership Group headed by the principal investigators (D. Sandberg and E. 
Vilain) and identified leaders from each member site, workgroups involving DSD team 
members from specialty areas, and affected individuals and advocates (http://dsdtrn.org/ for 
more details). Standardized assessment protocols (based on evidence and care guidelines) 
are provided to all sites, and diagnoses and interventions are prospectively and 
longitudinally captured in the network’s patient registry [30]. The DSD-TRN currently 
comprises 12 US sites that provide multidisciplinary DSD care; at the time of this study, 
there were 10 sites, 9 of which provided data included in this study (see Appendix I).
As has been done in other studies using the PAT, and with the agreement of the questionnaire 
designers, the PAT was modified slightly for the DSD population to create the PAT-DSD 
(changes noted in methods section). We anticipated the breakdown into PAT-DSD risk 
categories of families affected by DSD would approximate the proportions predicted by the 
PPPHM model and be similar to the risk categories found in other pediatric conditions using 
the PAT [11]. We also predicted that the PAT-DSD would demonstrate adequate internal 
reliability, as shown in previous studies of the PAT [e.g.,26, 27–29]. Finally, we predicted 
that the PAT-DSD would demonstrate evidence of construct validity in its relationships to 
scores on independent caregiver- and child-reported psychosocial measures.
Participants and Methods
Participant group
The participants were caregivers and their children enrolled in the DSD-TRN clinical 
registry. Across the 6 (of 9) sites that provided adequate participation data for calculation, an 
average of 67% (53%−90%) of eligible families were enrolled in the DSD-TRN. Reasons 
for families declining to participate are unknown; reasons noted by sites for not approaching 
families include time constraints, high patient or family distress such that DSD-TRN 
introduction was delayed and ultimately not completed, guardianship issues, and concern for 
over-burdening families due to involvement in other research studies. At time of data 
extraction 325 families were enrolled in the DSD-TRN.
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All caregiver-completed PAT-DSDs that were in the DSD-TRN clinical registry were 
extracted. PAT-DSDs had been completed by parents/caregivers in conjunction with a clinic 
visit at a DSD-TRN participating site. Families with multiple children with a DSD could 
consent for each child to be included in the DSD-TRN registry; however, to prevent 
individual families from being overrepresented within PAT-DSD risk categories, data from 
only the first child enrolled were included in the current analysis. The DSD-TRN 
psychosocial screening protocol calls for the PAT-DSD to be administered at the initial visit 
and annually thereafter [31]. The current analyses are restricted to the initial administration. 
Because the PAT-DSD was validated against other psychosocial measures completed by the 
same caregiver, three forms that listed the informant as “both parents” were excluded. The 
final data set comprised 197 PAT-DSD completed by caregivers (80% mothers; 17% fathers; 
3% other caregivers) of 197 unique patients with a DSD; this corresponded with 61% of the 
enrolled families. Of note, there was considerable variability among sites in terms of PAT-
DSD data availability (sites ranged from 6% - 89% of families with PAT-DSD data).
Measures
As part of the DSD-TRN model of care, caregivers and patients (8 years or older) completed 
a standardized assessment battery of commonly used and validated psychosocial measures 
[31]. Of note, patients and their caregivers were asked to complete the forms as part of 
standard clinical care, regardless of whether they had consented to have their clinical data 
entered into the DSD-TRN registry. Caregiver measures in the battery include the PAT-DSD, 
Patient Health Questionnaire-4 (PHQ-4) [32], Child Behavior Checklist (CBCL) [33] and 2 
measures designed for the DSD-TRN (Support and Resource Assessment, Knowledge of 
Condition). Patient measures include the Youth Self-Report (YSR) [33], Self-Perception 
Profile (SPP) [34, 35], Body Image Scale [36], Multidimensional Gender Identity Scale [37], 
and a measure designed for the DSD-TRN (Knowledge of Condition). Instruments were 
selected by a working group including pediatric behavioral health specialists and members 
of DSD advocacy and support groups, were developmentally sensitive, and were included 
only if there was an expectation that they could deliver immediately actionable information 
to DSD team providers at the clinical sites about the patient and family (e.g., identification 
of caregiver stress leading to consultation with a behavioral health provider) [31]. Sites 
adopted different approaches for the administration of the psychosocial battery; for example, 
at one site families were given the measures to complete during their clinic visit, while at 
another site families completed measures at home and returned them by mail. Estimated 
maximum time to complete the entire battery, based on information provided by test 
developers and clinical experience, is 45 minutes for caregivers and 55 minutes for patients.
The Psychosocial Assessment Tool-DSD version (PAT-DSD).—The PAT is a brief 
measure that takes a parent/guardian approximately 10 minutes to complete (paper/pencil, 
web-based and REDcap administration are available), and takes approximately 5 minutes to 
score and interpret, with a variety of scoring templates available [11]. It assesses seven 
psychosocial domains thought to be related to overall family risk; subscales include Family 
Structure/Resources, Social Support, Child Problems, Sibling Problems, Family Problems, 
Caregiver Stress Reaction and Family Beliefs. Subscale scores are an average of item 
responses within the subscale, and range from 0–1, with higher scores indicating greater 
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risk; the Total PAT score is a sum of subscale scores, and can range from 0–7. The total PAT 
score is used to determine risk category: < 1 = “Universal” risk; ≥ 1 and < 2 = “Targeted” 
risk; and ≥ 2 = “Clinical” risk. The PAT has been translated into multiple languages and the 
version on which the PAT-DSD was based has a fourth grade reading level [11]. Evidence 
for the reliability and validity of the PAT was first established in pediatric oncology [26], and 
has been found across a range of pediatric conditions with samples of caregivers of children 
from infancy through adolescence [27–29]. Of note, as has been done in other studies of the 
PAT, the PAT-DSD was modified slightly from the original PAT by substituting DSD-
specific language in place of references to “cancer,” and the demographic section was 
expanded slightly. In addition, because stigma is a notable concern for affected individuals 
with DSD and their families [38, 39], 3 items about stigma were added to create a Stigma 
subscale. These items were chosen from previous published research on a DSD stigma 
measure that incorporated stigma items from other questionnaires as well as the input of 
caregivers of children with DSD on their stigma concerns [38], and were as follows: “My 
child will be treated differently because of his/her condition”, “Having a urogenital 
condition attaches a stigma or label to my child”, “My child’s condition will put limits on 
his/her having a good life”. These items were not included in the PAT Total score 
computation, and were added at the end of the PAT, thereby minimizing influence on 
caregiver responding to previous items.
Validation measures.—To demonstrate evidence of construct validity of the PAT-DSD in 
this new population, only measures from the psychosocial battery which, a priori, were 
predicted to be related to domains represented in the PAT-DSD were included in the data 
analyses. These measures are listed in Table 1. Caregivers complete the PHQ-4 [32], a self-
reported screener for anxiety and depression and the parent-proxy (CBCL) [33] for children 
1.5 years of age and older to screen for child social competencies and emotional/behavioral 
problems; both of these measures are completed at the first visit and annually thereafter. 
Patients with a DSD who are 8 years of age or older complete the SPP for Children/
Adolescents [34, 35] to assess self-perceptions of domain-specific competencies or 
adequacies, and patients ≥ 11 years old complete the YSR [33], a self-report measure that 
parallels the CBCL. These measures are completed at the first visit that children meet the 
age eligibility requirement, with the CBCL and YSR completed annually and the SPP 
biannually thereafter. Only data from measures completed within 90 days of the PAT-DSD 
were used in analyses, and, for caregiver-report measures, only reports completed by the 
same caregiver completing the PAT-DSD were used. Sites were variable in how closely they 
followed the recommended administration schedule for measures. Thus, while the total n for 
the PAT-DSD is 197 families, the n is smaller for the validity analyses.
Statistical Analyses
Demographic information was extracted from the PAT-DSD form and diagnostic information 
was extracted from the DSD-TRN patient registry. Descriptive analyses were conducted on 
the demographic and diagnostic information as well as on the PAT-DSD Total and subscale 
scores. Risk category frequencies were also calculated. Internal consistency reliability (that 
is, the degree to which items are interrelated) for the PAT-DSD Total and each subscale was 
tested using a modified Cronbach’s alpha appropriate for binary responses (i.e., Kuder-
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Richardson-20 coefficient), with α ≥ 0.70 considered “acceptable” [40]. Criterion and 
convergent validity of the PAT-DSD were explored to document evidence of construct 
validity [41, 42]. Criterion validity measures the degree to which a test predicts a specific 
outcome. In this case, we examined the ability of the PAT-DSD Total score to predict 
functioning as ascertained by the validation measures (i.e., PHQ-4, CBCL, YSR and SPP) 
by first estimating bivariate correlations of the Total score with those measures and, second, 
by conducting analyses of variance (Welch’s robust ANOVAs with post hoc Tukey HSD 
tests) to determine if classification according to PAT-DSD risk category was associated with 
mean differences on those measures. Convergent validity of the PAT-DSD subscales was 
evaluated by calculating bivariate correlation coefficients of specific subscales with 
validation measures assessing similar constructs (Table 1). Alpha was set to 0.05 for all 
analyses, with P values < 0.1 considered to be a statistical trend. Statistical analyses were 
completed using SPSS Version 23.
Results
Participant group characteristics
The group was primarily white and non-Hispanic (Table 2). The median patient age at time 
of PAT-DSD completion was 6.7 years; 22% of the patients were less than 1 years old. The 
majority of patients were being raised as girls (59%); 1 child (1 month old at time of PAT-
DSD completion) was being raised gender-neutral and 1 youth (17 years old) had initially 
been assigned female gender at birth but had self-initiated gender reassignment to male as an 
adolescent. 46,XY and 46,XX DSD were equally represented in the group, and were more 
prevalent than sex chromosome DSD (41.6%, 42.1%, 10.2%, respectively). While 49.2% of 
patients had received a confirmed genetic diagnosis, many patients carried a confirmed or 
provisional diagnosis based on a combination of endocrinologic and phenotypic findings. 
Diagnoses in the 46,XY category included partial and complete androgen insensitivity, 17-
beta hydroxysteroid dehydrogenase deficiency, and penoscrotal hypospadias (etiology 
unknown); in the 46,XX category included congenital adrenal hyperplasia, ovotesticular 
DSD, and Mayer-Rokitansky-Küster-Hauser syndrome; and in the Sex Chromosome DSD 
category included mixed gonadal dysgenesis, mosaic Turner syndrome, and case-specific 
deletions (e.g., Xp22.31 deletion). PAT-DSDs were typically completed by mothers, and the 
majority of caregiver informants had some college education.
PAT-DSD Total and subscale scores were comparable to the values found in other studies of 
pediatric conditions using the PAT [29, 43] (Table 3). The mean (SD) Total score for the 
group was 0.86 (0.65), which fell in the Universal level of risk. However, nearly a third of 
the group demonstrated some level of psychosocial risk (66.0% Universal risk, 27.9% 
Targeted risk and 6.1% Clinical level of risk), mirroring the general distribution of risk 
categories previously identified by the PAT (see Figure 1 for comparison with a sampling of 
conditions [11, 28, 43, 44]; for more complete comparison see review [11]).
Internal Consistency Reliability
The PAT-DSD Total score demonstrated good internal consistency reliability (α = 0.86; 
Table 3), comparable to previous studies of the PAT that reported internal consistency (e.g., 
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oncology α = 0.81 [26]; kidney transplant α = 0.82 [27]; IBD α = 0.82 [28]; headache α = 
0.80 [29]). PAT-DSD Social Support, Child Problems, Sibling Problems and Family 
Problems all showed acceptable reliability (all α > 0.70), with Caregiver Stress Reaction 
slightly below the acceptable range (α = 0.65). The subscales of Family Resources/Structure 
and Caregiver Beliefs demonstrated inadequate reliability; previous studies have found these 
same subscales to show poorer reliability [26–29]. Our newly added Stigma Concerns 
subscale did not meet acceptable criteria for reliability.
Construct Validity
As evidence of criterion validity, the PAT-DSD Total score correlated positively with the 
predicted caregiver-reported (PHQ-4: r = 0.43, P < 0.001; CBCL: r = 0.61, P < 0.001) and 
patient self-reported (YSR: r = 0.37, P = 0.011) measures of parent and child emotional 
distress/behavioral disturbance (Table 4). In addition, caregiver distress varied significantly 
according to PAT-DSD risk category [F(2, 15.12) = 5.91, P = 0.013], with mean (SD) PHQ-4 
scores of 1.03 (1.88), 1.78 (2.26) and 5.43 (3.60) for the Universal, Targeted and Clinical 
risk levels, respectively; Universal and Targeted groups differed significantly from the 
Clinical risk group, but not from each other. Similarly, scores on measures of child 
emotional/behavioral functioning on both the caregiver-reported CBCL [F(2, 14.18) = 13.07, 
P < 0.001] and the patient self-reported YSR [F(2, 9.82) = 5.86, P = 0.021] differed 
significantly according to PAT-DSD risk category. For the CBCL, scores for the Targeted 
and Clinical risk groups were significantly higher than the Universal risk group, but not 
different from each other; the mean (SD) CBCL Total score was 44.19 (11.09), 55.89 
(12.21) and 62.67 (11.38) for the Universal, Targeted and Clinical risk levels, respectively. 
For the YSR, the Universal and Targeted risk groups significantly differed; the mean (SD) 
YSR Total T score was 47.41 (6.52), 56.28 (9.00) and 54.00 (15.91) for the Universal, 
Targeted and Clinical risk levels, respectively.
Evidence for convergent validity was also demonstrated (Table 4). As predicted, the PAT-
DSD Child Problems subscale positively correlated with the CBCL (r = 0.80, P < 0.001) and 
YSR (r = 0.43, P = 0.003) and negatively correlated with the SPP Global Self-Worth scale (r 
= −0.35, P = 0.024). Also as predicted, the PAT-DSD Family Problems and Caregiver Stress 
Reaction subscales were both positively correlated with the PHQ-4 (r = 0.47, P < 0.001; r = 
0.46, P < 0.001, respectively). Although not predicted a priori, the PAT-DSD Family 
Problems subscale also correlated with both caregiver- and self-reported patient emotional/
behavioral problems (CBCL: r = 0.40, P < 0.001; YSR: r = 0.47, P = 0.001). Smaller 
unpredicted associations were found between the PAT-DSD Social Support subscale and 
PHQ-4 (r = 0.29, P = 0.002) and the PAT-DSD Sibling Problems subscale and CBCL (r = 
0.29, P = 0.032), such that 1) higher caregiver distress was related to lower social support 
and 2) higher caregiver-reported patient emotional/behavioral concerns were associated with 
higher caregiver-reported sibling problems.
Discussion
This study is the first to examine the psychometric properties of a broad psychosocial 
screener, the PAT-DSD, in the pediatric DSD population. Our study provided evidence for 
Ernst et al. Page 9
Horm Res Paediatr. Author manuscript; available in PMC 2020 February 15.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
the reliability and validity of the PAT-DSD; in particular, the PAT-DSD Total score 
demonstrated good internal reliability and evidence of criterion validity in that it was 
correlated with other measures of emotional/behavioral functioning as predicted. The PAT-
DSD Total score was positively correlated to measures completed by both the same 
informant (PHQ-4 and CBCL) and a different informant (YSR), strengthening confidence in 
this finding. In addition, the classification of the PAT-DSD Total score into household levels 
of risk resulted in a risk stratification similar to other pediatric populations, with the risk 
groups differing in both caregiver and child emotional-behavioral functioning. The PAT-
DSD subscales were variable in terms of internal reliability, with subscales measuring the 
emotional/behavioral functioning of family members and family social support (Social 
Support, Child Problems, Sibling Problems, Family Problems and Caregiver Stress 
Reaction) demonstrating the highest internal consistency. Convergent validity of subscales 
was also supported as these subscales significantly correlated in the expected direction with 
independent measures of overlapping constructs. Thus, our study provides preliminary 
support for the use of the PAT-DSD as a screener for psychosocial risk in families with a 
patient with DSD.
Given that a third of these families affected by DSD reported risk factors that might be 
barriers to resilient adaptation, identification of a broad and user-friendly screener for the 
DSD population may have a beneficial clinical impact. In other populations, use of the PAT 
has correlated with increased mention of psychosocial risk factors in the medical record, and 
increased utilization of psychosocial services relative to standard of care [44, 45]. Level of 
psychosocial follow-up care aligned with risk category in some [27, 45], but not all [46] 
previous studies, suggesting that identification of high-risk families may lead to greater 
allocation of resources. Notably, in a randomized controlled pilot study with a sample of 
children with cancer, those families whose PAT information at Time 1 was systematically 
provided to their treatment team demonstrated significant reduction in risk on the PAT as 
measured 6 months later relative to families whose PAT information was not communicated 
[47]. While these findings using the PAT in other conditions are encouraging, future studes 
of utility of the PAT-DSD within the DSD population are needed.
Health prevention models emphasize that families in all risk categories benefit from 
interventions designed to promote resilience and mitigate risk factors. Potential DSD-
specific interventions across risk level categories are listed in Table 5. Universal care for all 
families should include high-quality education, connection with peer support, and team 
emphasis on essential components of resiliency including developmentally-sensitive 
information-sharing with children. In addition, all families should be offered consultation 
with a behavioral health specialist familiar with DSD and their implications. Families 
identified as falling in the Targeted risk category can be prioritized to have access to 
behavioral health providers with interventions addressing specific concerns, such as a 
pediatric psychologist providing brief behavioral interventions to assist with medication 
adherence or involvement of social work to assist with resource identification. Families 
scoring in the Clinical risk range will likely require extended access to behavioral health 
during clinic visits, with identification of outpatient support, close follow-up by the 
multidisciplinary care team and, possibly, more extensive utilization of community agencies 
providing wrap-around services. Research in other pediatric populations suggests that 
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parent- and family-focused interventions such as cognitive-behavioral therapy or problem-
solving interventions can benefit parent adaptation, child coping and medical symptoms 
[48]. Of course, in resource-poor communities, bolstering family resilience may remain 
challenging, but the use of a screening tool may focus efforts on those with most need.
Any screening tool must be integrated into clinic flow for it to be effectively utilized with 
patients, and future research will need to determine the utility of the PAT for health care 
providers working with patients affected by a DSD. Providers will need to determine the 
most efficient system based on available resources: for example, in one setting a behavioral 
health provider may administer, score and review with the family and team, whereas in 
another setting a nurse may administer and score and then convey risk level to a behavioral 
health provider and/or the medical team. Previous research on stakeholder perspectives of 
the PAT in other populations find that caregivers describe the PAT as short and easy to 
complete, and likely to facilitate difficult conversations about risk factors [49]; studies of 
health providers find that some providers have concern about the length of time it takes to 
assist families completing the PAT; however, some providers in systems with a standardized 
work flow for the PAT report that PAT administration and scoring is simple with a minimal 
impact on workflow [50]. There are a number of administration and scoring options (e.g., 
paper and pencil, web-based; https://www.psychosocialassessmenttool.org/using-pat). 
Provider stakeholders have also noted that having a member of the team who will educate 
other members on the importance of screening and advance the screening process is 
essential for successful implementation [50]. The optimal screening schedule may differ 
according to the pediatric population, but certainly time of diagnosis or first contact with 
family offers the opportunity to provide preventive psychosocial care. Finally, health care 
systems must have a financial model that supports access to behavioral health providers and 
allied health professionals trained in evidence-based approaches to ameliorating 
psychosocial risk and identifying and supporting family strengths to optimize adjustment.
Limitations of the study
A limitation of our study is that several PAT-DSD subscales did not meet criteria for 
adequate internal reliability. Of note, these subscales typically had fewer items in the scale 
(e.g., Caregiver Stress and Caregiver Beliefs); additional items might strengthen internal 
reliability [51]. In particular, the 3-item Caregiver Stigma Concern subscale that we added to 
modify the PAT specifically for the DSD population did not demonstrate adequate internal 
reliability. Caregivers highlight significant concerns at the time of diagnosis related to 
stigma, and indicate that they make treatment decisions related to these concerns [38, 52]. 
Accordingly, further work on identifying different or additional items that, as a group, more 
reliably screen for stigma is indicated. These items could be identified by looking at other 
measures of stigma in this population [38]. However, one strength of the PAT is its brevity, 
so any additional items should be carefully selected and tested to avoid unnecessarily 
lengthening the measure. In addition, because these data were collected as part of a clinical 
registry protocol conducted at multiple sites with varying availability of administrative 
resources, patient enrollment and measure administration rates differed across sites, and we 
lack detailed information related to family nonparticipation in the DSD-TRN and our 
incomplete measure data.
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Conclusion
Our study provides evidence supporting the psychometric merit of the PAT-DSD, 
particularly the Total score and risk categories. The variability in internal consistency of the 
PAT-DSD subscales underscores that the PAT-DSD is best understood as a screener of 
overall psychosocial risk, and individual items within the subscales should guide clinical 
conversations rather than using subscale scores to diagnose any specific psychological 
disorder or to capture change in response to an intervention. Our study also suggests that 
families with DSD may have psychosocial risk factors that could complicate DSD care. A 
family’s ability to manage treatment burden will likely be enhanced when these risk factors 
are identified and resources are provided to mitigate psychosocial risk. Use of a 
psychosocial screener, such as the PAT-DSD, at initial point of entry may be a step toward 
providing comprehensive care as envisioned in multiple care guidelines for individuals 
affected by DSD and their families [1, 13–16], particularly in less resource-rich 
communities. Given that DSDs pose long-term health, psychological and socioeconomic 
challenges for some individuals [53–55], early prevention or intervention efforts may set the 
stage for more resilient adaptation over a lifetime. Future studies should investigate the 
utility of the PAT-DSD for triaging available resources to families and testing the impact of 
these resource on the quality of life of affected persons and their families.
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Figure 1. 
Comparison of the Psychosocial Assessment Tool-DSD (PAT-DSD) risk category 
distribution (in current study, n = 197) versus Psychosocial Assessment Tool (PAT) risk 
category distribution in comparable pediatric populations.
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Table 2.
Participant group demographic and diagnostic information (n = 197)
Children
Age (yrs), median (range) 6.7 (1 day – 22.5 years)
White, n (%) 137 (69.5)
Hispanic, n (%) 57 (28.9)
Gender at time of study, n (%)
 Girl 117 (59.4)
 Boya 79 (40.1)
 Gender-neutral 1 (0.5)
Gender n (% of category)
DSD category, n (%) Girl Boy Gender-neutral
 Sex chromosome DSD 20 (10.2) 7 (35.0) 13 (65.0) 0 (0.0)
 46,XY DSD 82 (41.6) 30 (36.6) 52 (63.4)a 0 (0.0)
 46,XX DSD 83 (42.1) 73 (88.0) 9 (10.8) 1 (1.2)
 Karyotype unavailable 12 (6.1) 7 (58.3) 5 (41.7) 0 (0.0)
Caregiver Informants
 Mother, n (%) 150 (76.1)
 White, n (%) 138 (70.1)
Educational background n (%)b
  ≤ High school education 43 (21.8)
  College courses/degrees 113 (57.4)
  Postgraduate education 39 (19.8)
a
Includes one youth who was assigned female gender at birth but in adolescence self-initiated reassignment to male gender.
b
Educational background missing for 2 caregivers
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Table 5.
Example DSD-related interventions across the Psychosocial Assessment Tool-DSD risk levels
Risk level Potential interventions
Universal
Connect with peer support
Provide high-quality written and verbal education
 Specific DSD etiology, course and treatment options
 Distinctions between biological sex (sex chromosomes, gonads, internal/external anatomy) and psychosocial differentiation 
(gender identity, gender role, sexual orientation)
 Natural variability in appearance
Promote family-centered care and active involvement in shared decision-making
Discuss importance of information sharing (particularly to affected child)
Offer behavioral health consultation (unless universally involved)
Address complex shared-decision making challenges (e.g., prior to child’s ability to participate themselves in irrevocable non-
urgent decisions)
Explore stigma-related concerns (e.g., distinguish “privacy” vs “shame/secrecy,” problem-solve social challenges)
Provide routine clinic follow-up
Targeted
Offer Universal interventions (see above)
Meet with in-clinic behavioral health specialist / psychologist for further assessment of identified concerns
Practice communication skills (e.g., disclosure to others, developmentally appropriate education to child)
Involve other hospital resources to address specific concerns (e.g., Social Work, Chaplaincy, Child Life)
Implement behavioral interventions (e.g., medication adherence, healthy food choices/ exercise for weight management)
Teach brief emotion regulation strategies (e.g., to assist with coping with medical exams/ procedures, mild/transient mood 
concerns)
Teach problem-solving interventions (e.g., medication management during overnight party)
Provide shorter-term follow-up to assess efficacy of interventions and need for more intensive services
Clinical
Offer appropriately timed Targeted and Universal interventions (Note: these may not be effective when families are in acute crisis)
Conduct safety assessment & planning
Provide immediate crisis intervention
Refer for outpatient counseling
Involve community services
Provide close phone follow-up to support follow-through with additional referrals/services
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